Connect with us
European Gaming Congress 2024

Artificial Intelligence

Todos Medical and 3DMed Enter Into Coronavirus (COVID-19) and Influenza A/B Testing Kit Distribution Agreement in US and Israel

Published

on


 3DMed test demonstrated 99.3% sensitivity and 100% specificity in Chinese clinical trial Nucleic Acid test performed on proprietary automated platform to increase throughput CE Mark and China FDA approval have been received; 3DMed in discussions with US FDA and WHO Technology was deployed in Wuhan, China with over 100,000 tests completed Combination coronavirus and influenza A/B testing novel among PCR approachesREHOVOT, Israel and New York, NY, March 17, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Todos Medical Ltd. (OTCQB: TOMDF), a pre-commercial stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, today announced that it has entered into a non-exclusive distribution agreement with 3DMedicine Science & Technology Co (3DMed), a China-based cancer precision medicine company, for distribution in the US and Israel of 3DMed’s ANDiS® SARS-CoV-2 Detection Kit (COVID), ANDiS® SARS-CoV-2  & Influenza A/B Detection Kit (COVID/Flu) and its proprietary ANDiS®350 3DMed Automated Solution countertop real-time PCR machine (3D Machine). 3DMed’s COVID, COVID/Flu and 3D Machine have received a CE Mark in Europe. 3D Machine also has received approval from the Chinese FDA. 3DMed is currently engaged in discussions with the FDA regarding approval of its products. “I am very pleased to help Todos and 3DMed bring this technology forward for commercial launch in the US under CLIA, and help support FDA approval for 3DMed’s suite of products here in the United States as quickly as possible,” said Jorge Leon, PhD, Chief Medical Advisor to Todos. “The main differentiation in the 3DMed offering vs. other nucleic acid PCR-based testing is the influenza A and B tests combined with coronavirus testing. This is a clinically meaningful combination because of the extended flu season in the United States that will create additional doubt among healthcare providers regarding the cause of symptoms for patients. The fact that this will be available in one testing paradigm seems to be novel in the United States.”Concurrent with this announcement, Todos and Provista Diagnostics, Inc. have agreed to use Provista’s lab in Alpharetta, Georgia to conduct the CLIA validation required to launch the test in the United States. All inquiries should be directed via email to [email protected]. Rao Mulpuri, PhD, MBA Chief Operating Officer of Provista, commented, “Todos Medical and Provista Diagnostics will work together to complete the validation and make the product available to healthcare providers in a timely manner.”  3D BioMed has shipped materials to the Provista lab in Georgia in order to support the validation being conducted over the coming weeks.“PCR is the current gold standard for diagnosing novel coronavirus in the United States and abroad,” said Gerald Commissiong, President & CEO of Todos. “We believe 3DMed’s ANDiS® 350 and kits provide some of the best results in the market because of the engineering applied in establishing the automation that reduces variability and human error in the lab, while increasing throughput. We intend to work expeditiously to validate this technology at Provista, so that we can come online in the US and add additional critically needed testing capacity to the nation’s infrastructure.”“The 2019-20 coronavirus pandemic becomes an ongoing global pandemic of coronavirus disease. We have got many lessons in coronavirus fighting in Wuhan, China in the past few months and want to share the experiences with the rest of the world. Fully automated viral RNA extraction systems and precise nucleic acid detection kits played critical roles in rapidly diagnosing coronavirus disease 2019 with a large scale in Wuhan, China,” said Simon Shung, President & CEO of 3DMed. “Meanwhile, to distinguish between early symptoms of the flu and coronavirus would become very important since people may feel similar to those suffering from their symptoms. We hope to help the US and other countries stop the coronavirus spreading through the collaboration with Todos by doing more precise nucleic acid tests with our products, which were validated by tons of cases in the past few months.” “We’re thrilled to work with Todos, a well-recognized innovative Dx company,” said Caifu Chen, Chief Technology Officer of 3DMed. “Two young technology companies share common goals in fighting cancer and now the new global 2019-nCoV epidemic brings us together to stop its spreading by precisely identifying virus infected individuals using highly sensitive and specific proprietary RT-qPCR assays developed at 3DMed. Our past experiences in catching this terrible virus in Wuhan areas will help Todos build high-performance 2019-nCoV test labs in the US in a record time.”About Todos Medical Ltd.Todos Medical Ltd. is an in-vitro diagnostic company engaged in the development of blood tests for the early detection of a variety of cancers, and also has initiated the development of blood tests for neurodegenerative disorders such as Alzheimer’s disease through Breakthrough Diagnostics, Inc., its joint venture with Amarantus Bioscience Holdings, Inc. Todos has developed two cancer screening tests based on TBIA (Todos Biochemical Infrared Analyses), a method for cancer screening using peripheral blood analysis. The TBIA screening method is based on the cancer’s influence on the immune system, which triggers biochemical changes in peripheral blood mononuclear cells and plasma. This proprietary and patented method incorporates biochemistry, physics and signal processing. The company’s two cancer screening tests, TM-B1 and TM-B2, have received the CE mark. Todos owns 19.99% of Breakthrough Diagnostics, Inc., a joint venture with Amarantus Bioscience Holdings, Inc. (OTCPK:AMBS) that is developing the LymPro Test®, a blood test for diagnosing Alzheimer’s disease. Todos has exercised its option to acquire Breakthrough, and expects to close on that transaction in the first half of 2020. Todos has also entered into an exclusive option to acquire breast cancer blood testing company Provista Diagnostics, Inc. that is commercializing the Videssa® breast cancer blood test. For more information, the content of which is not part of this press release, please visit http://www.todosmedical.comAbout 3DMed3D Medicines (3DMed), founded in 2010, is a leading precision medicine company in China with a vision to provide earlier and precision diagnosis to each patient. 3DMed’s set the standard for innovation in automated molecular diagnostic products and artificial intelligence (AI) to help doctors provide patients with personalized and precision treatments. 3DMed has a College of American Pathologists (CAP) accredited and Clinical Laboratory Improvement Amendments (CLIA) certified laboratory to provide clinical tests in various applications. 3DMed is constantly innovating and evolving its capabilities in automating and streamlining molecular diagnostic processes and genome data analysis. In 2018, 3DMed offered an AI-based cancer genome data interpretation system, ANDiS® Genome Insight. Later in 2019, 3DMed launched the world’s first fully closed automated NGS library-prep system, ANDiS® 400 into the clinical market. 3DMed is dedicated to be a game changer in automated molecular diagnostics.At the early stage of the outbreak of coronavirus 2019 (COVID-2019) in Wuhan, Hubei Province in China, 3DMed developed a series of real-time RT-qPCR based tests (ANDiS® SARS-CoV-2 Detection Kit , ANDiS® SARS-CoV-2  & Influenza A/B Detection Kit) to qualitatively detect nucleic acids of SARS-CoV-2 in upper and lower respiratory specimens collected from individuals who meet CDC criteria for COVID-19 testing. For more information, the content of which is not part of this press release, please visit http://www.3dmedcare.comForward-looking StatementsCertain statements contained in this press release may constitute forward-looking statements. For example, forward-looking statements are used when discussing our expected clinical development programs and clinical trials. These forward-looking statements are based only on current expectations of management, and are subject to significant risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval or patent protection for product candidates; competition from other biotechnology companies; and our ability to obtain additional funding required to conduct our research, development and commercialization activities. In addition, the following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: changes in technology and market requirements; delays or obstacles in launching our clinical trials; changes in legislation; inability to timely develop and introduce new technologies, products and applications; lack of validation of our technology as we progress further and lack of acceptance of our methods by the scientific community; inability to retain or attract key employees whose knowledge is essential to the development of our products; unforeseen scientific difficulties that may develop with our process; greater cost of final product than anticipated; loss of market share and pressure on pricing resulting from competition; and laboratory results that do not translate to equally good results in real settings, all of which could cause the actual results or performance to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, Todos Medical does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For a more detailed description of the risks and uncertainties affecting Todos Medical, please refer to its reports filed from time to time with the U.S. Securities and Exchange Commission.Investor and Corporate Contact:Kim Sutton GolodetzLHA Investor RelationsSenior Vice President  (212) 838-3777[email protected] 
Corporate ContactDaniel HirschTodos MedicalInvestor RelationsEmail: [email protected] Phone: (347) 699-0029

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Lucinity Partners with Sift for Unified Fraud and AML Case Management

Published

on

lucinity-partners-with-sift-for-unified-fraud-and-aml-case-management

SAN FRANCISCO, Sept. 19, 2024 /PRNewswire/ — Lucinity and Sift have announced a partnership, unifying fraud and Anti-Money Laundering (AML) into Lucinity’s integrated FinCrime compliance platform for case management, agent-enabled workflow automation, and Generative AI.

Sift is an AI-powered fraud platform securing digital trust for leading global businesses. Its Global Data Network analyzes more than 1 trillion events and identity signals per year to prevent fraud across the entire consumer journey. Lucinity and Sift formed this new partnership to address the challenges of fragmented fraud and AML systems, aiming to centralize and enhance financial crime investigations.
Sift’s AI-powered solution will now be integrated into Lucinity’s platform. This collaboration enhances Lucinity’s ability to provide a seamless and efficient compliance solution. It allows teams to review and manage fraud alerts more effectively through Lucinity’s unified Case Management system, thanks to the native integration between the systems. Key benefits to Lucinity’s users include:
Real-Time Fraud Screening: Payments are screened for potential fraud in real time, utilizing Sift’s fraud detection capabilities.Automatic Payment Holds: Payments suspected of fraud are temporarily held, ensuring verification before processing.Streamlined Reviews: Compliance teams can conduct thorough reviews of flagged payments within Lucinity’s Case Management solution.Risk Level Adjustments: Fraud detection parameters can be customized to adjust sensitivity levels, adapting to emerging fraud trends and risk appetites.This partnership also enables users to leverage Lucinity’s Generative AI capabilities through the Luci copilot to investigate fraud cases more efficiently.
Udi Nessimyan, President and Chief Revenue Officer of Lucinity, comments, “One of the greatest challenges in fighting financial crime is fragmented systems and data. Our partnership with Sift helps address this challenge by providing a centralized platform for various case types, including AML, fraud, sanctions, and ad hoc cases. Our collaboration significantly enhances the productivity of investigation teams, reducing the time spent on cases from hours to minutes.”
Sift’s Chief Marketing Officer, Armen Najarian, emphasizes the collaborative effort to enhance financial crime prevention, stating, “Cybercriminals are increasingly leveraging AI to bypass traditional anti-money laundering and fraud controls, creating sophisticated and dynamic threats. To combat these evolving risks, companies must adopt a ‘fight fire with fire’ approach by leveraging AI-powered solutions. Through Sift’s partnership with Lucinity, businesses can stay ahead of fraudsters, ensuring robust protection against abuse and enabling fearless growth.”
About Sift: https://sift.com About Lucinity: https://lucinity.com
Media contact:Celina [email protected] +354 792 4321

View original content:https://www.prnewswire.co.uk/news-releases/lucinity-partners-with-sift-for-unified-fraud-and-aml-case-management-302253487.html

Continue Reading

Artificial Intelligence

Employee Background Check Software Market Size to Grow USD 828.8 Million by 2030 at a CAGR of 4.9% | Valuates Reports

Published

on

employee-background-check-software-market-size-to-grow-usd-8288-million-by-2030-at-a-cagr-of-4.9%-|-valuates-reports

BANGALORE, India, Sept. 19, 2024 /PRNewswire/ — Employee Background Check Software Market is Segmented by Type (Cloud-Based, On Premises), by Application (SMEs, Large Enterprises): Global Opportunity Analysis and Industry Forecast, 2024-2030.

The Global Employee Background Check Software Market was valued at USD 587 Million in 2023 and is anticipated to reach USD 828.8 Million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-2A10579/Global_Employee_Background_Check_Software 
Major Factors Driving the Growth of Employee Background Check Software Market:
The employee background check software market is growing due to increasing demands for secure hiring processes and regulatory compliance, especially in industries such as finance, healthcare, and IT. As companies look to reduce risks associated with fraud, legal liabilities, and workplace safety, background checks are becoming a critical part of recruitment processes. The rise of remote work has further accelerated the need for digital solutions. However, challenges include concerns over data privacy and varying legal frameworks across regions, which may slow adoption in some areas.
Buy Now: https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-2A10579&lic=single-user
TRENDS INFLUENCING THE GROWTH OF THE GLOBAL EMPLOYEE BACKGROUND CHECK SOFTWARE MARKET:
Cloud-based background check software is gaining traction due to its scalability, remote access, and cost-effectiveness. With cloud-based systems, businesses can streamline their hiring processes, particularly when operating across multiple locations. The ability to access data and conduct checks in real-time is highly valuable for organizations managing large workforces or remote employees. The flexibility and lower upfront investment of cloud-based solutions make them popular among businesses seeking efficient and adaptable systems for their recruitment processes.
On-premises solutions remain important for organizations with strict security and data control requirements, such as those in government, defense, or finance. These companies often need complete ownership of their data, which on-premises software offers, reducing the risk of external breaches. Although it requires significant upfront investment and maintenance, on-premises software provides a high level of customization and security. It’s especially useful for businesses dealing with sensitive information and industries where compliance with local data protection laws is critical.
Large enterprises, particularly those operating in regulated industries like banking and healthcare, are the major adopters of employee background check software. These organizations deal with large volumes of hires, making streamlined background checks essential for compliance and operational efficiency. The ability to integrate background check systems with existing HR tools, such as applicant tracking systems, allows large companies to manage their recruitment processes more effectively. The need for comprehensive and accurate background checks is crucial for mitigating risk and ensuring legal compliance.
The rise in remote working has increased the demand for background check software that allows companies to vet employees regardless of their location. Digital background checks, particularly cloud-based ones, make it easier for organizations to screen remote workers efficiently. This trend is expected to continue as more companies adopt hybrid or fully remote work models, where geographical barriers no longer restrict talent acquisition but require thorough and remote-friendly verification processes.
As regulatory frameworks for employment practices become more stringent globally, businesses are increasingly relying on background check software to ensure compliance. Laws like the General Data Protection Regulation (GDPR) in Europe and the Fair Credit Reporting Act (FCRA) in the U.S. have made it mandatory for companies to conduct background checks within specific legal parameters. This has led to increased demand for software solutions that can automate these processes while maintaining compliance with regional and international laws.
A major trend in the employee background check software market is the integration of these solutions with human resources management systems (HRMS). Integrating background checks with HR software streamlines the hiring process by consolidating background checks, employee records, and onboarding into one system. This improves operational efficiency for businesses, particularly large enterprises that handle significant recruitment volumes. Integration with HRMS allows for real-time updates, making background screening an even more integral part of the hiring process.
View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-2A10579/global-employee-background-check-software 
EMPLOYEE BACKGROUND CHECK SOFTWARE MARKET SHARE
North America dominates the market due to stringent employment regulations and widespread adoption across industries. Europe is another key region, driven by GDPR compliance and demand in finance and healthcare. The Asia-Pacific region is experiencing rapid growth due to increasing awareness of the importance of background checks, especially in countries like China and India, where digital hiring platforms are becoming more popular. The market is also expanding in the Middle East and Africa as businesses prioritize secure hiring practices.
Key Companies:
HireRightGoodHireCheckrSterlingHireologyINTELIFIGood EggPeopleG2VitayCertnGlobal HR ResearchVeritable ScreeningXrefZincPaycomADPVICTIGIntelliCorp (Cisive)SpringVerifyAsurintUniversalAssureHireVerified FirstHireSafePurchase Chapters: https://reports.valuates.com/request/chaptercost/QYRE-Auto-2A10579/Global_Employee_Background_Check_Software 
SUBSCRIPTION
We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.
DISCOVER MORE INSIGHTS: EXPLORE SIMILAR REPORTS!
–  Employer of Record Services market was valued at USD 128.2 Million in 2023 and is anticipated to reach USD 196 Million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
–  Employee Engagement Platform market was valued at USD 805 Million in 2023 and is anticipated to reach USD 2217.4 Million by 2030, witnessing a CAGR of 15.5% during the forecast period 2024-2030.
–  Employee Advocacy Platforms market was valued at USD 533 Million in 2023 and is anticipated to reach USD 1020.8 Million by 2030, witnessing a CAGR of 9.7% during the forecast period 2024-2030.
–  Employee Feedback Software market is projected to grow from USD 499.5 Million in 2024 to USD 1287.8 Million by 2030, at a Compound Annual Growth Rate (CAGR) of 17.1% during the forecast period.
–  Employee Productivity Tracking Software market is projected to reach USD 311.8 Million in 2029, increasing from USD 219 Million in 2022, with the CAGR of 5.2% during the period of 2023 to 2029.
–  Employee Feedback Software market is projected to grow from USD 499.5 Million in 2024 to USD 1287.8 Million by 2030, at a Compound Annual Growth Rate (CAGR) of 17.1% during the forecast period.
–  Employee Rewards and Recognition Software Market
–  Employee Productivity Monitoring Software Market
–  Employee Recognition Software market was valued at USD 2247 Million in 2023 and is anticipated to reach USD 4186.4 Million by 2030, witnessing a CAGR of 8.9% during the forecast period 2024-2030.
–  Employee Lockers Market
DISCOVER OUR VISION: VISIT ABOUT US!
Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.
Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that’s why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.
To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.
YOUR FEEDBACK MATTERS: REACH OUT TO US!Valuates [email protected] U.S. Toll-Free Call 1-(315)-215-3225WhatsApp: +91-9945648335Website: https://reports.valuates.comBlog: https://valuatestrends.blogspot.com/Pinterest: https://in.pinterest.com/valuatesreports/Twitter: https://twitter.com/valuatesreportsFacebook: https://www.facebook.com/valuatesreports/YouTube: https://www.youtube.com/@valuatesreports6753https://www.facebook.com/valuateskorean https://www.facebook.com/valuatesspanish https://www.facebook.com/valuatesjapanese https://valuatesreportspanish.blogspot.com/ https://valuateskorean.blogspot.com/ https://valuatesgerman.blogspot.com/ https://valuatesreportjapanese.blogspot.com/ 
Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/employee-background-check-software-market-size-to-grow-usd-828-8-million-by-2030-at-a-cagr-of-4-9–valuates-reports-302253435.html

Continue Reading

Artificial Intelligence

Shang Haifeng from Huawei Cloud: Building a Resilient, Intelligent Hybrid Cloud and Taking an Intelligence Leap

Published

on

shang-haifeng-from-huawei-cloud:-building-a-resilient,-intelligent-hybrid-cloud-and-taking-an-intelligence-leap

SHANGHAI, Sept. 19, 2024 /PRNewswire/ — The Hybrid Cloud Infra Forum 2024, with the theme, “Dive into Cloud and Leap to a New Horizon”, convened at HUAWEI CONNECT 2024 today. At the event, Shang Haifeng, CEO of Huawei Mainframe Modernization BU and President of Huawei Hybrid Cloud, announced the launch of Huawei Cloud Stack 8.5. The new version introduces a new solution, Mainframe-to-Cloud Solution, and includes more use cases for Hybrid Cloud for Large AI Models.

Jacqueline Shi, President of Huawei Cloud Global Marketing and Sales Service, stated in her opening speech: “Thanks to the strong support from our customers, Huawei Cloud’s hybrid cloud business has been continuously expanding in the global market. An increasing number of customers from sectors, such as government, finance, education, healthcare, transportation, mining, and power have joined forces with Huawei Cloud to drive innovation. Huawei Cloud Stack synchronizes a wide array of services from the Huawei public cloud and can be deployed on-premises, breaking through technological barriers and meeting customer demands. With leading technologies, a mature platform, and a robust local ecosystem, we provide our customers with cutting-edge, scenario-specific solutions. Looking ahead, Huawei Cloud looks forward to continuing our collaboration with customers to develop superior hybrid cloud solutions and embark on the digital transformation journey together.”
Today, hybrid cloud has become the preferred foundation for digital transformation of government organizations and large enterprises. Huawei Cloud has been continuously investing in R&D, committed to providing government and enterprise customers with a sustainable and optimal hybrid cloud foundation.
Shang Haifeng said: “Cloud transformation of core systems and intelligent production have become the twin pillars for government and enterprise customers diving into cloud. Huawei Cloud Stack will innovate in resilience and intelligence, elevating the hybrid cloud to a new horizon and helping customers move faster to take a smart, digital leap.”
A New Horizon of Resilience: Creating a New Mainframe-to-Cloud Benchmark
As industries have been accelerating cloud adoption, the migration of core systems to the cloud represents the final piece of the all-cloud puzzle. It is a gateway to comprehensive intelligence. However, this migration poses many challenges, spanning hardware, software, security, O&M, optimization, and tools. It is an end-to-end comprehensive project that requires software-hardware synergy.
This year, Huawei established a Mainframe Modernization BU, consolidating core R&D strengths across compute, storage, network, cloud, and the Central Research Institute to drive systematic innovation. This initiative aims to fully exploit the power of software-hardware synergy to overcome the world-class challenge of mainframe migration to cloud. They have been persistent in developing an independent and innovative technology system to ensure an ongoing supply of core technologies. The team has been stepping up efforts to develop comprehensive system engineering capabilities, from infrastructure and implementation processes to O&M, aiming to establish new core systems on the cloud.
The Mainframe-to-Cloud Solution from Huawei provides comprehensive disaster recovery (DR) for all scenarios, supports modular application deployment, and enables multi-site multi-active DR, satisfying a spectrum of availability requirements. It supports hardware fault detection in seconds, which makes O&M for large-scale clusters more efficient. The application-centric end-to-end visibility speeds up fault identification and troubleshooting. Seamless cloud OS upgrades enable the parallel upgrade of hundreds of nodes without VM migration, and without any service interruptions.
Huawei maximizes the synergy between software and hardware. Hardware NIC virtualization passthrough and the multi-core lock-free design reduce the latency of a single forward for load balancing by 83% and increase the forwarding bandwidth of a single cluster to 400 Gbit/s. Passthrough networking simplifies the network from two layers to just one, which reduces latency by 40%. Moreover, the fusion of the RoCE network and NoF+ protocol slashes end-to-end storage latency by 50%. All of these enable unparalleled performance and superior experiences.
In terms of security, GaussDB, a fully-encrypted database, and Kunpeng Trusted Execution Environment (TEE) safeguard against data breaches and minimize performance degradation, keeping it within 20%.
Shang Haifeng expressed that Huawei aspires to set new trustworthiness standards for mainframe-to-cloud migration through innovation in foundational technologies and experience consolidation. Huawei aims to take the resilience of core systems to a new horizon and provide a better choice for the world.
A New Horizon of Intelligence: Launch of Top Use Cases of Hybrid Cloud for Large AI Models
The past two years have witnessed fast development in large models. An increasing number of industries are exploring and adopting large models, forging new business models and substantially expanding market demands. New technologies and new use cases are key to the adoption of large models across industries.
In 2023, Huawei Cloud Stack launched the industry’s first Hybrid Cloud for Large AI Models, empowering enterprises to build their own large AI models in one stop. In June this year, Huawei Cloud Stack introduced 10 new technologies for Hybrid Cloud for Large AI Models, making them easier to deploy using different infrastructures, algorithms, and engineering capabilities. Additionally, Huawei Cloud Stack curates high-quality datasets, consolidates model application experience, and is fully integrated into industry ecosystems, making the use cases easier.
Huawei Cloud Stack also uses the innovative ModelArts engineering tool suite that consists of three modules: data, model, and application. It is designed to expedite AI engineering adoption, simplifying the creation, training, and deployment of large models.
At the forum, Huawei Cloud unveiled the top use cases for Hybrid Cloud for Large AI Models, targeting five major industries. 20 domain-specific and over 80 industry scenario-specific use case baselines were launched. Shang Haifeng highlighted that these use case baselines are rooted in delivered projects, covering solutions, services, and partners. They are ready for broad promotion and replication. In the future, Huawei Cloud Stack will update use cases twice a year, always delivering more use cases and superior solutions to customers.
Leveraging the powerful capabilities and experience of Huawei Cloud Stack and Pangu Models, Huawei Cloud will elevate intelligence to a new horizon, enabling every enterprise to create their own large model.
At the forum, the 2024 Global “Dive into Cloud Polaris” Awards Ceremony was held to honor global benchmark customers and partners who have made outstanding contributions to cutting-edge technologies, scenarios, and model exploration with Huawei Cloud. A total of 18 government organizations and enterprises around the world from diverse sectors, such as government, finance, oil and gas, and transportation, earned the awards.
The journey ahead is still filled with challenges. Moving forward, Huawei Cloud Stack will persist in innovating and breaking new ground, continuously refining technical solutions, optimizing product portfolios, and diving into industry scenarios. The intelligent world is just around the corner. Huawei Cloud Stack looks forward to joining hands with government and enterprise customers to leap to a new horizon and embrace a better future.
Photo – https://mma.prnewswire.com/media/2510123/Huawei_Cloud_1.jpgPhoto – https://mma.prnewswire.com/media/2510124/Huawei_Cloud_2.jpgPhoto- https://mma.prnewswire.com/media/2510125/Huawei_Cloud_3.jpg

View original content:https://www.prnewswire.co.uk/news-releases/shang-haifeng-from-huawei-cloud-building-a-resilient-intelligent-hybrid-cloud-and-taking-an-intelligence-leap-302253418.html

Continue Reading
Advertisement
Advertisement

Latest News

Trending